Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards
暂无分享,去创建一个
[1] G. Doern. In Vitro Susceptibility Testing of Haemophilus influenzae: Review of New National Committee for Clinical Laboratory Standards Recommendations , 1993, Journal of clinical microbiology.
[2] G. Doern. In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations , 1992 .
[3] D. Low,et al. Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group , 1992, Journal of clinical microbiology.
[4] J. Heelan,et al. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines , 1992, Journal of clinical microbiology.
[5] J. Jorgensen,et al. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Ronald N. Jones,et al. The re-evaluation of the NCCLS ampicillin susceptibility tests with Haemophilus test medium: New interpretive criteria for the disk diffusion method , 1992 .
[7] C. Rivet. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[8] J. Jorgensen,et al. Reproducibility of disc susceptibility tests with Haemophilus influenzae. , 1991, The Journal of antimicrobial chemotherapy.
[9] G. Doern,et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States , 1990, Antimicrobial Agents and Chemotherapy.
[10] B. Catlin. Branhamella catarrhalis: an organism gaining respect as a pathogen , 1990, Clinical Microbiology Reviews.
[11] T. Stull,et al. Problems with current recommendations for susceptibility testing of Haemophilus influenzae , 1990, Antimicrobial Agents and Chemotherapy.
[12] G. Doern,et al. In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods , 1988, Antimicrobial Agents and Chemotherapy.
[13] J. Jorgensen,et al. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae , 1987, Journal of clinical microbiology.
[14] G. Doern,et al. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents , 1987, Antimicrobial Agents and Chemotherapy.
[15] M. Bergeron,et al. Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics , 1987, Journal of clinical microbiology.
[16] T. Stull,et al. Problems withCurrent Recommendations forSusceptibility Testing ofHaemophilus influenzae , 1990 .
[17] G. Doern,et al. InVitro Activities of39Antimicrobial Agents forBranhamella catarrhalis andComparison ofResults withDifferent Quantitative Susceptibility TestMethods , 1988 .